440 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Bought by Hanson & Doremus Investment Management

Hanson & Doremus Investment Management bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 440 shares of the medical equipment provider’s stock, valued at approximately $230,000.

Several other hedge funds also recently added to or reduced their stakes in ISRG. State Street Corp increased its holdings in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares in the last quarter. FMR LLC increased its stake in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Geode Capital Management LLC raised its holdings in Intuitive Surgical by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after purchasing an additional 143,440 shares during the period. Fisher Asset Management LLC boosted its position in Intuitive Surgical by 1.8% during the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after purchasing an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. grew its holdings in Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 28,843 shares of company stock valued at $15,357,560 over the last quarter. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

ISRG stock opened at $572.71 on Thursday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm has a market cap of $203.99 billion, a PE ratio of 92.08, a PEG ratio of 5.19 and a beta of 1.39. The firm’s 50 day moving average price is $548.70 and its 200-day moving average price is $507.04.

Analyst Ratings Changes

A number of research analysts have recently issued reports on ISRG shares. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday. Citigroup lifted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, UBS Group increased their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.